Researcher in lab

Find clinical trials

Our clinical trial portfolio is one of the largest in the country. We have more than 600 clinical trials open across 30 clinical units.

Find Melbourne Sexual Health Centre research studies and clinical trials
Clear filter
604 clinical trials found
Clinical trials

SAHARA_

Aneurysmal Subarachnoid Hemorrhage -Red Blood Cell Transfusion and Outcome (SAHaRA): A Randomized Controlled Trial. (NCT03309579)

Recently completed/closed

SALSA

Stopping Antiviral Therapy in People with HBeAg-negative CHB and Low Surface Antigen (Trial Not Registered)

Currently recruiting

SEAFARER

Subscalp EEG Augmentation For Accuracy and Reliability in Epilepsy Reviews (ACTRN12625000231448)

Currently recruiting

SeaLAND

An ALLG phase 3 randomised trial of Selinexor and Lenalidomide versus lenalidomide maintenance post Autologous stem cell transplant for patients with Newly Diagnosed multiple myeloma (SeaLAND) (ACTRN12620000291987)

Currently recruiting

SEARCH

Screening for Early onset Amyloid Related Cerebral Hemorrhage

Currently recruiting

Seelos SLS-005

A double-blind, randomized, placebo-controlled trial to assess safety and efficacy of SLS-005 (trehalose injection, 90.5 mg/mL for intravenous infusion) for the treatment of adults with spinocerebellar ataxia (NCT05490563)

Currently recruiting

SEL002

A Phase 2b Randomised Controlled Trial of Sodium Selenate as a Disease Modifying Treatment for Probable Behavioural Variant Fronto-temporal Dementia (ACTRN12620000236998)

Currently recruiting

SEL003

A Phase 2 Randomised Controlled Trial of Sodium Selenate as a Disease Modifying Treatment for Probable Progressive Supranuclear Palsy (ACTRN12620001254987)

Currently recruiting

SELECT

A Phase 2 Randomised Controlled Trial of Sodium Selenate as a Disease Modifying Treatment for Chronic Drug-Resistant Temporal Lobe Epilepsy (ACTRN12623000446662)

Currently recruiting

SGNB6A-002 [Be6A Lung-01]

A randomized, phase 3, open-label study to evaluate SGN-B6A compared with docetaxel in adult subjects with previously treated non-small cell lung cancer (NCT06012435)

No longer recruiting

SGNTUC-029

An Open-label Randomized Phase 3 Study of Tucatinib in Combination with Trastuzumab and mFOLFOX6 versus mFOLFOX6 given with or without either Cetuximab or Bevacizumab as First-line Treatment for Subjects with HER2+ Metastatic Colorectal Cancer (NCT05253651)

Currently recruiting

SHR3162-III-305

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined with Abiraterone Acetate and Prednisone (AA-P) versus Placebo Combined with AA-P as First-Line Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer (NCT04691804)

No longer recruiting

SiroSkin

A randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients (NCT05860881)

Currently recruiting

SISS

Switching patients from intravenous to subcutaneous infliximab in inflammatory bowel disease (ACTRN12621001498886)

Currently recruiting

SLN124-004

Phase 1/2 study with an open-label dose escalation phase followed by a randomized, double-blind phase of SLN124 in patients with Polycythemia Vera (NCT05499013)

Currently recruiting

SMITE

SMITE: Superiority of Migraine Inpatient Treatment with Eptinezumab (ACTRN12621001616864)

Currently recruiting

SNAP

Staphylococcus aureus Network Adaptive Platform trial (SNAP) (NCT05137119)

Currently recruiting

SNaPP Study

Sugammadex, neostigmine and postoperative pulmonary complications (the SNaPP Study) (ACTRN12623000394640)

Currently recruiting

SNDX-5613-0700

A Phase 1/2, Open-label, Dose-Escalation and Dose-Expansion Cohort Study of SNDX-5613 in Patients with Relapsed/Refractory Leukemias, Including Those Harboring an MLL/KMT2A Gene Rearrangement or Nucleophosmin 1 (NPM1) Mutation (NCT04065399)

Currently recruiting

SNDX-5613-0708

Phase 1, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate Safety, Tolerability, and Clinical Activity of SNDX-5613 in Combination with Intensive Chemotherapy in Participants with Newly Diagnosed Acute Myeloid Leukemias Harboring Alterations in Lysine-specific Methyltransferase 2A [KMT2A/MLL], Nucleophosmin 1 [NPM1], and Nucleoporin 98 [NUP98] Genes (NCT06226571)

Coming soon
24 25 26 27 28